Abena Agyepong
Primary Podiatric Medicine · Cincinnati, OHNPI 1689248775
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 43.7% of the total. Reporting peaked in 2022 at $1,635 and has fallen 98.6% since, to $22 in 2025.
Across 25 payments — averaging $111.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$1K
- Integra Lifesciences Corporation$375
- Smith+Nephew$197
- Stryker$167
- BD$119
- Bioventus LLC$105
- plus $599 from 11 others
What the payments were for
- Food & beverage$1,57557%
- Education$1,20043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 2 | $1,213 |
| Integra Lifesciences Corporation | 4 | $375 |
| Smith+Nephew | 2 | $197 |
| Stryker | 2 | $167 |
| BD | 1 | $119 |
| Bioventus LLC | 2 | $105 |
| Kerecis Limited | 1 | $102 |
| Organogenesis Inc. | 2 | $99 |
| AbbVie | 1 | $83 |
| Amgen | 1 | $71 |
| Solventum Corporation | 1 | $70 |
| Melinta Therapeutics, LLC | 1 | $58 |
| Cardiovascular Systems Inc. | 1 | $49 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| In2bones USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$348
- Kerecis Omega3 Marigen$305
- PRIMATRIX$237
- INTEGRA DERMAL REGENERATION TEMPLATE$237
- INTEGRA MESHED BILAYER WOUND MATRIX$121
- INTEGRA WOUND MATRIX (IWM)$121
- INTEGRA FLOWABLE WOUND MATRIX$121
- ARISTA AH FLEXITIP$119
- INFINITY ADAPTIS$118
- INVISION$118
- INBONE$118
- Stravix$110
- Kerecis Omega3 SurgiClose$102
- Kerecis Omega3 GraftGuide$102
How this compares
Too few primary podiatric medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 17 | $261 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Cincinnati
- Brock LidenCircleville$453K
- Shital PemaKettering$299K
- Megan OltmannSolon$177K
- Gary MostChesterland$4K
- Thomas CiresiRichmond Heights$4K
- Tiffany LiuDublin$3K
- David BaerColumbiana$3K
- Samuel MakanjuolaColumbus$2K
- Matthew NarducciColumbiana$2K
- Joseph ArtersYoungstown$937
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.